Harvard Bioscience/$HBIO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Harvard Bioscience
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
Ticker
$HBIO
Sector
Primary listing
Employees
328
Headquarters
Website
HBIO Metrics
BasicAdvanced
$27m
-
-$2.22
1.57
-
Price and volume
Market cap
$27m
Beta
1.57
52-week high
$7.50
52-week low
$4.27
Average daily volume
32k
Financial strength
Current ratio
1.99
Quick ratio
0.908
Long term debt to equity
423.751
Total debt to equity
439.2
Interest coverage (TTM)
0.38%
Profitability
EBITDA (TTM)
7.823
Gross margin (TTM)
58.42%
Net profit margin (TTM)
-11.44%
Operating margin (TTM)
2.55%
Effective tax rate (TTM)
1.16%
Revenue per employee (TTM)
$260,000
Management effectiveness
Return on assets (TTM)
1.73%
Return on equity (TTM)
-78.65%
Valuation
Price to revenue (TTM)
0.313
Price to book
2.69
Price to tangible book (TTM)
-4.34
Price to free cash flow (TTM)
20.866
Free cash flow yield (TTM)
4.79%
Free cash flow per share (TTM)
0.288
Growth
Revenue change (TTM)
-6.42%
Earnings per share change (TTM)
-83.26%
3-year revenue growth (CAGR)
-9.27%
10-year revenue growth (CAGR)
-2.47%
3-year earnings per share growth (CAGR)
64.22%
10-year earnings per share growth (CAGR)
-8.60%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs